.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Pharmaceutical companies with the most 'New Combination' drugs

This chart shows the companies which have received the most New Combination exclusivities in the past five years.

New Combinations are one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'

Alternate categories worth of three years of protection include identifying a New Patient Population, New Product, or New Strength.

The companies with the most New Combination drugs are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc